Reata Pharmaceuticals, Inc. Debt to Equity Ratio 2016-2023 | RETA
Current and historical debt to equity ratio values for Reata Pharmaceuticals, Inc. (RETA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Reata Pharmaceuticals, Inc. debt/equity for the three months ending June 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-06-30 | $0.42B | $0.09B | 4.76 |
| 2023-03-31 | $0.58B | $-0.13B | -4.47 |
| 2022-12-31 | $0.58B | $-0.07B | -8.83 |
| 2022-09-30 | $0.58B | $0.01B | 128.24 |
| 2022-06-30 | $0.56B | $0.07B | 8.20 |
| 2022-03-31 | $0.55B | $0.13B | 4.32 |
| 2021-12-31 | $0.55B | $0.19B | 2.95 |
| 2021-09-30 | $0.48B | $0.26B | 1.86 |
| 2021-06-30 | $0.46B | $0.31B | 1.48 |
| 2021-03-31 | $0.45B | $0.37B | 1.21 |
| 2020-12-31 | $0.44B | $0.42B | 1.05 |
| 2020-09-30 | $0.43B | $0.19B | 2.30 |
| 2020-06-30 | $0.42B | $0.23B | 1.82 |
| 2020-03-31 | $0.44B | $0.23B | 1.91 |
| 2019-12-31 | $0.43B | $0.26B | 1.66 |
| 2019-09-30 | $0.33B | $-0.07B | -4.84 |
| 2019-06-30 | $0.33B | $-0.03B | -9.98 |
| 2019-03-31 | $0.34B | $-0.01B | -72.86 |
| 2018-12-31 | $0.33B | $0.02B | 21.77 |
| 2018-09-30 | $0.35B | $0.04B | 9.18 |
| 2018-06-30 | $0.34B | $-0.17B | -2.04 |
| 2018-03-31 | $0.28B | $-0.14B | -1.96 |
| 2017-12-31 | $0.28B | $-0.15B | -1.92 |
| 2017-09-30 | $0.29B | $-0.13B | -2.21 |
| 2017-06-30 | $0.30B | $-0.23B | -1.31 |
| 2017-03-31 | $0.31B | $-0.22B | -1.40 |
| 2016-12-31 | $0.30B | $-0.22B | -1.41 |
| 2016-09-30 | $0.31B | $-0.21B | -1.48 |
| 2016-06-30 | $0.33B | $-0.21B | -1.54 |
| 2016-03-31 | $0.34B | $-0.27B | -1.24 |
| 2015-12-31 | $0.35B | $-0.27B | -1.29 |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
